Terumo Medical Care Solutions – Pharmaceutical Solutions Division (PSD) aspires to be the preferred partner of pharma customers for innovative medical devices and injectable drug delivery solutions, providing safe and effective products that improve people’s lives. Our integrated Contract Development and Manufacturing Organization (CDMO) services include the sterile fill‑finish of injectable drug products in polymer prefillable syringes (PFS) and glass vials.
Our range of high-quality needles, syringes, infusion sets, and primary packaging prefillable syringes (PFS) can support the requirements of many pharmaceutical and biotechnology companies located around the globe.
Terumo Pharmaceutical Solutions Integrated CDMO Services
Terumo Pharmaceutical Solutions’ integrated CDMO model is built on “Design Right First Time” with decisions based on our “Quality First” principle which will increase the customer’s confidence in the project’s success along with potentially delivering optimized speed and lower total costs.
Key strengths of Terumo Pharmaceutical Solutions’ unique integrated CDMO model include:
- Integration built around fill–finish excellence
Work with customers to support drug product design and primary container selection, while keeping usability and manufacturability in mind. - In-house polymer prefillable syringe (PFS) primary container design and manufacturing leadership
Terumo designs its polymer PFS to deliver quality products that contribute to optimal drug product performance. - Connected execution with in-house engineering
Fewer transfer interfaces, faster troubleshooting, and steadier schedules that are all aligned with your “Time to market” objectives. - Aligned Quality & Regulatory Governance
Common governance for quality and regulatory readiness - Terumo Pharmaceutical Solutions CDMO Drug Product Development
Offering full scope of sterile injectable formulation optimization, prefilled syringe material compatibility studies and co-development of primary container specifications.
- Intradermal Injection Needle
Designed to deliver vaccines and other approved drugs to the dermal layer of the skin for improved immune response in comparison to intramuscular or subcutaneous injections1. - Needle Depth Control
Innovative needle design to ensure injection in dermal layer of the skin2. - Perpendicular Insertion
Limiter ring guides the needle for perpendicular insertion into the patient’s deltoid region of the arm3.
References
1. Intradermal Delivery of Vaccines, A review of the literature and the potential for development for use in low- and middle-income countries, August 27, 2009
2. Shimizu, Sakiko et al. “Performance and usability evaluation of novel intradermal injection device Immucise™ and reanalysis of intradermal administration trials of influenza vaccine for the elderly.” Vaccine vol. 40,6 (2022): 873-879
3. Traditional 510(k) K190427– Immucise™ Intradermal Injection System: Device Description
Connect with our Experts for Tailored Support